• No results found

Clinical Development of PD-1/PD-L1 Immunotherapy for Gastrointestinal Cancers: Facts and Hopes.

N/A
N/A
Protected

Academic year: 2020

Share "Clinical Development of PD-1/PD-L1 Immunotherapy for Gastrointestinal Cancers: Facts and Hopes."

Copied!
42
0
0

Loading.... (view fulltext now)

Full text

Loading

Figure

Table 1 Selected on-going randomised studies evaluating PD-(L)1 antibodies in gastrointestinal cancers
Figure 1

References

Related documents

Many emission processes that can generate hard X-ray photons can also result in the linear polarization of those hard X-ray photons. 1 The level of

FHS: Framingham Heart Study; GWAS: Genome-wide association study; TCV: Total intracranial volume; WMH: White matter hyperintensities.. Acknowledgements

primarily hoped to enrich the lives of the Powerloom workers and people in the district. It is also envisaged that the success of these pilots will effectively

enzymes produced by alkaliphilic microorganisms such as xylanases, amylases, proteases, 79.. dextranases, xylosidases, chitinases, cellulase, alginases, catalase, RNase, DNase,

[r]

With the passage of the Presidential Libraries Act of 1955, the same system used to create and administer the Roosevelt Library became the official government procedure for the

Clinical outcomes of treatment with filgrastim versus a filgrastim biosimilar and febrile neutropenia- associated costs among patients with nonmyeloid cancer undergoing

The main goal of this work was the study of the function of Rad5 for the repair of gamma induced lesions, since the rad5 mutant presents a moderate sensitivity towards this